Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis

Molecular and Cellular Biochemistry

Volumn 364, Issue 1-2, 2012, Pages 165-171

  Wang, Fengze ^a   Fei, Hongrong ^a   Qi, Bing ^a   Yao, Shutong ^b   Chang, Zhengyao ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b School of Basic Medical Sciences   (China)

Author keywords

Angiogenesis; ENOS; HBXIP; Hepatoma cells; HUVECs

Indexed keywords

BINDING PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEPATITIS B X INTERACTING PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CHORIOALLANTOIS; CONTROLLED STUDY; EGG; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, HEPATOCELLULAR; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863989694     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1215-5     Document Type: Article

References (20)

1. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7(6):448-458. doi:10.1038/nrgastro.2010.100
2. Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H (2011) Angiogenesis in chronic liver disease and its complications. Liver Int 31(2):146-162. doi:10.1111/j. 1478-3231.2010.02369.x
3. De Castro Junior G, Puglisi F, de Azambuja E, El Saghir NS, Awada A (2006) Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the "do ut des" paradigm). Crit Rev Oncol Hematol 59(1):40-50. doi:10.1016/j.critrevonc.2006. 02.007 (Pubitemid 43903280)
4. Shojaei F, Zhong C, Wu X, Yu L, Ferrara N (2008) Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18(8):372-378. doi:10.1016/j.tcb.2008.06.003
5. Melegari M, Scaglioni PP, Wands JR (1998) Cloning and characterization of a novel hepatitis B virus × binding protein that inhibits viral replication. J Virol 72(3):1737-1743 (Pubitemid 28100722)
6. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22(11):2729-2740. doi: 10.1093/emboj/cdg263 (Pubitemid 36712369)
7. Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S, Zhang H, Kim Y, Bennett CF, Jiang W, Reed JC (2006) HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66(18):9099-9107. doi:10.1158/0008-5472. CAN-06-1886 (Pubitemid 44521129)
8. Wang FZ, Fei HR, Lian LH, Wang JM, Qiu YY (2011) Hepatitis B x-interacting protein induces HepG2 cell proliferation through activation of the phosphatidylinositol 3-kinase/Akt pathway. Exp Biol Med Maywood 236(1):62-69. doi:10.1258/ebm.2010.010 179
9. Lamalice L, Le Boeuf F, Huot J (2007) Endothelial cell migration during angiogenesis. Circ Res 100(6):782-794. doi:10.1161/01. RES.0000259593.07661.1e (Pubitemid 46555683)
10. Tsai WL, Chung RT (2010) Viral hepatocarcinogenesis. Oncogene 29(16):2309-2324. doi:10.1038/onc.2010.36
11. Benhenda S, Cougot D, Buendia MA, Neuveut C (2009) Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 103:75-109. doi: 10.1016/S0065-230X (09) 03004-8
12. Lupberger J, Hildt E (2007) Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13(1):74-81 (Pubitemid 46165464)
13. Shai E, Varon D (2011) Development, cell differentiation, angiogenesis-microparticles and their roles in angiogenesis. Arterioscler Thromb Vasc Biol 31(1):10-14. doi:10.1161/ATVB AHA.109.200980
14. Tang J, Wang J, Zheng F, Kong X, Guo L, Yang J, Zhang L, Huang Y (2010) Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 339(1-2):107-118. doi: 10.1007/s11010-009- 0374-0
15. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC (1998) Direct evidence for the importance of endotheliumderived nitric oxide in vascular remodeling. J Clin Invest 101(4):731-736. doi:10.1172/JCI1699 (Pubitemid 28096068)
16. Gonzalez E, Kou R, Lin AJ, Golan DE, Michel T (2002) Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem 277(42):39554-39560. doi:10.1074/jbc. M207299200 (Pubitemid 35190934)
17. Daher Z, Boulay PL, Desjardins F, Gratton JP, Claing A (2010) Vascular endothelial growth factor receptor-2 activates ADPribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J Biol Chem 285(32):24591-24599. doi:10.1074/jbc. M110.115311
18. Hu Z, Chen J, Wei Q, Xia Y (2008) Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function: co-commitment and interplay of Akt and AMPK. J Biol Chem 283(37):25256-25263. doi:10.1074/jbc. M802455200
19. Kandalaft LE, Motz GT, Busch J, Coukos G (2011) Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. Curr Top Microbiol Immunol 344:129-148. doi:10.1007/82-2010-95
20. Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY (2010) Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 70(21):8812-8821. doi:10.1158/0008-5472. CAN-10-0551